Abstract:Abstract Acute kidney injury (AKI) is a public health problem with no specific therapies in the clinic, and the underlying pathogenesis of AKI remains obscure. Bombesin receptor-activated protein(BRAP, C6ORF89 protein) was initially discovered as a ligand for a previously orphan G protein-coupled receptor bombesin-like receptor-3. At present, accepted biological effects of BRAP include cell cycle progression, wound repair, and the activation of histone deacetylases. However, its role in kidney disease is unknown. In this study, we have investigated the role of BRAP and underlying mechanisms involved in cisplatin-induced AKI. BRAP was down-regulated in mice and human kidneys with AKI. Global Bc004004(homologous of C6ORF89 in mice) deletion alleviated tubular cell apoptosis and necroptosis in cisplatin-induced AKI mice, whereas local overexpression of BRAP in kidneys aggravated them. The pan-caspase inhibitor Z-VAD pretreatments attenuated cisplatin-induced blood creatinine increase and kidney injury in wild-type mice, but not in BRAP-/- mice. The activation of MLKL was magnified by Z-VAD in cisplatin-treated mice, especially in BRAP-/- mice. The cytoprotective effect of Z-VAD was more substantial than Necrostatin-1(Nec-1, an inhibitor of necroptosis) in CP-treated human kidney proximal tubular epithelial (HK2) cells. Furthermore, Nec-1pretreatment reduced the CP-induced cell death in BRAP overexpression HK2 cells but did not work in cells with normal BRAP levels. We determined that cisplatin treatment activated NF-κB subunit P65, and inhibition of P65 increased the mRNA levels of BRAP in HK2cells. ChIP assay and Dual-luciferase reporter gene assay verified P65 binding to the C6ORF89 promoter and reduced its mRNA expression upon cisplatin treatment. Next, we found that SIRT2 was downregulated in cisplatin-induced AKI, and BRAP levels directly impacted the protein levels of SIRT2. Our findings further confirmed that BRAP regulates the SIRT2 protein levels by affecting SIRT2’s interactions with E3 ubiquitin ligase HRD1 and subsequent proteasomal degradation. Collectively, our results demonstrated that BRAP played an important role in tubular cell apoptosis and necroptosis during cisplatin-induced AKI. Safe and efficient BRAP inhibitors might be effective therapeutic options for AKI.

APOBEC-1 deletion enhances cisplatin-induced acute kidney injury

RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.

Bombesin receptor-activated protein exacerbates cisplatin-induced AKI by regulating the degradation of SIRT2

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection

A Novel Renoprotective Strategy: Upregulation of PD-L1 Mitigates Cisplatin-Induced Acute Kidney Injury

Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1

Cisplatin induces acute kidney injury and pyroptosis in mice through the exosome miR-122/ELAVL1 regulatory axis

SENP1 protects cisplatin-induced AKI by attenuating apoptosis through regulation of HIF-1α

Ameliorative effects of miR-186 on cisplatin-triggered acute kidney injury via targeting ZEB1

Role of Cisplatin in Inducing Acute Kidney Injury and Pyroptosis in Mice Via the Exosome Mir-122/Elavl1 Regulatory Axis.

Pharmacological and Genetic Inhibition of Fatty Acid-Binding Protein 4 Alleviated Cisplatin-Induced Acute Kidney Injury

#5658 TUBULE-SPECIFIC CYCLIN-DEPENDENT KINASE 12 KNOCKDOWN POTENTIATES KIDNEY INJURY THROUGH TRANSCRIPTIONAL ELONGATION DEFECTS

TCR<SUP>+</SUP>CD4<SUP>-</SUP>CD8<SUP>-</SUP> (double negative) T cells protect from cisplatin-induced renal epithelial cell apoptosis and acute kidney injury

Renalase protects against cisplatin acute kidney injury in mice

Protective role of apigenin in cisplatin-induced renal injury.

Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression

Histone methyltransferase MLL1 drives renal tubular cell apoptosis by p53-dependent repression of E-cadherin during cisplatin-induced acute kidney injury

Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function

Inhibition of CXCL1-CXCR2 axis ameliorates cisplatin-induced acute kidney injury by mediating inflammatory response

Bioactive Peptide Apelin Rescues Acute Kidney Injury by Protecting the Function of Renal Tubular Mitochondria